Nick Beije

1.0k total citations
25 papers, 548 citations indexed

About

Nick Beije is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Oncology. According to data from OpenAlex, Nick Beije has authored 25 papers receiving a total of 548 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 13 papers in Cancer Research and 12 papers in Oncology. Recurrent topics in Nick Beije's work include Cancer Genomics and Diagnostics (12 papers), Cancer Cells and Metastasis (7 papers) and Prostate Cancer Treatment and Research (7 papers). Nick Beije is often cited by papers focused on Cancer Genomics and Diagnostics (12 papers), Cancer Cells and Metastasis (7 papers) and Prostate Cancer Treatment and Research (7 papers). Nick Beije collaborates with scholars based in Netherlands, Belgium and Italy. Nick Beije's co-authors include Stefan Sleijfer, John W.M. Martens, Agnes Jager, Maurice P.H.M. Jansen, Jaco Kraan, Jean Helmijr, Silvia Rita Vitale, Lindsay Angus, Ronald de Wit and Lisanne F. van Dessel and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and British Journal of Cancer.

In The Last Decade

Nick Beije

23 papers receiving 539 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nick Beije Netherlands 12 383 261 212 178 89 25 548
Ninad Dewal United States 6 305 0.8× 194 0.7× 228 1.1× 206 1.2× 75 0.8× 9 514
Marco Petronio France 4 313 0.8× 407 1.6× 166 0.8× 113 0.6× 37 0.4× 5 567
Samia Melaabi France 10 199 0.5× 200 0.8× 152 0.7× 166 0.9× 120 1.3× 22 456
Yuji Shimoda Japan 10 229 0.6× 210 0.8× 133 0.6× 132 0.7× 99 1.1× 26 410
Katja Fischereder Austria 9 461 1.2× 223 0.9× 262 1.2× 350 2.0× 115 1.3× 13 695
Maria Chimonidou Greece 11 536 1.4× 284 1.1× 513 2.4× 178 1.0× 55 0.6× 13 758
Imke Müller Germany 8 329 0.9× 183 0.7× 228 1.1× 199 1.1× 69 0.8× 8 494
Amber Anderson United States 8 385 1.0× 515 2.0× 147 0.7× 166 0.9× 43 0.5× 8 618
Pauline Gilson France 12 223 0.6× 224 0.9× 182 0.9× 84 0.5× 99 1.1× 34 432
Brian Datnow United States 8 168 0.4× 254 1.0× 173 0.8× 116 0.7× 57 0.6× 16 444

Countries citing papers authored by Nick Beije

Since Specialization
Citations

This map shows the geographic impact of Nick Beije's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nick Beije with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nick Beije more than expected).

Fields of papers citing papers by Nick Beije

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nick Beije. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nick Beije. The network helps show where Nick Beije may publish in the future.

Co-authorship network of co-authors of Nick Beije

This figure shows the co-authorship network connecting the top 25 collaborators of Nick Beije. A scholar is included among the top collaborators of Nick Beije based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nick Beije. Nick Beije is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stevens, Michiel, John W.M. Martens, Jaco Kraan, et al.. (2025). PSA Secretion from Single Circulating Tumor Cells of Metastatic Castration-Naïve Prostate Cancer Patients. Cancer Research Communications. 5(8). 1359–1371.
2.
Dessel, Lisanne F. van, Vanja de Weerd, Corine M. Beaufort, et al.. (2025). Cell‐free DNA aneuploidy score as a dynamic early response marker in prostate cancer. Molecular Oncology. 19(10). 2822–2832. 1 indexed citations
3.
Martens, John W.M., et al.. (2024). A review of trials investigating ctDNA-guided adjuvant treatment of solid tumors: The importance of trial design. European Journal of Cancer. 207. 114159–114159. 10 indexed citations
4.
Rescigno, Pasquale, Maria D. Fenor de la Maza, Stephanie Burnett, et al.. (2024). Phase II trial of pembrolizumab for patients suffering from metastatic castration resistant prostate cancer (mCRPC) with DNA repair defects, high tumour mutation burden, and/or high CD3 counts (PERSEUS1).. Journal of Clinical Oncology. 42(4_suppl). 138–138. 1 indexed citations
5.
Beije, Nick, et al.. (2023). PARP inhibitors for prostate cancer. Seminars in Oncology. 51(1-2). 25–35. 12 indexed citations
6.
Tanis, Pieter J., Henk M.W. Verheul, John W.M. Martens, et al.. (2023). Circulating tumour DNA as biomarker for rectal cancer: A systematic review and meta-analyses. Frontiers in Oncology. 13. 1083285–1083285. 11 indexed citations
7.
Vitale, Silvia Rita, Lisanne F. van Dessel, Nick Beije, et al.. (2021). Detection of tumor-derived extracellular vesicles in plasma from patients with solid cancer. BMC Cancer. 21(1). 315–315. 27 indexed citations
8.
Beije, Nick, et al.. (2020). Liquid Biopsies to Select Patients for Perioperative Chemotherapy in Muscle-invasive Bladder Cancer: A Systematic Review. European Urology Oncology. 4(2). 204–214. 22 indexed citations
9.
Beije, Nick, John W.M. Martens, & Stefan Sleijfer. (2019). Incorporating liquid biopsies into treatment decision-making: obstacles and possibilities. Drug Discovery Today. 24(9). 1715–1719. 8 indexed citations
10.
Duinhouwer, Lucia, Nick Beije, Bronno van der Holt, et al.. (2018). Impaired thymopoiesis predicts for a high risk of severe infections after reduced intensity conditioning without anti-thymocyte globulin in double umbilical cord blood transplantation. Bone Marrow Transplantation. 53(6). 673–682. 6 indexed citations
11.
Sieuwerts, Anieta M., Bianca Mostert, Michelle van der Vlugt‐Daane, et al.. (2018). An In-Depth Evaluation of the Validity and Logistics Surrounding the Testing of AR-V7 mRNA Expression in Circulating Tumor Cells. Journal of Molecular Diagnostics. 20(3). 316–325. 15 indexed citations
12.
Vitale, Silvia Rita, Anieta M. Sieuwerts, Nick Beije, et al.. (2018). An Optimized Workflow to Evaluate Estrogen Receptor Gene Mutations in Small Amounts of Cell-Free DNA. Journal of Molecular Diagnostics. 21(1). 123–137. 14 indexed citations
13.
Beije, Nick, Jaco Kraan, Michael A. den Bakker, et al.. (2017). Improved diagnosis and prognostication of patients with pleural malignant mesothelioma using biomarkers in pleural effusions and peripheral blood samples – a short report. Cellular Oncology. 40(5). 511–519. 5 indexed citations
14.
15.
Beije, Nick, Anieta M. Sieuwerts, Jaco Kraan, et al.. (2017). Estrogen receptor mutations and splice variants determined in liquid biopsies from metastatic breast cancer patients. Molecular Oncology. 12(1). 48–57. 50 indexed citations
16.
17.
Angus, Lindsay, Nick Beije, Agnes Jager, John W.M. Martens, & Stefan Sleijfer. (2016). ESR1 mutations: Moving towards guiding treatment decision-making in metastatic breast cancer patients. Cancer Treatment Reviews. 52. 33–40. 71 indexed citations
18.
Beije, Nick, Wendy Onstenk, Jaco Kraan, et al.. (2016). Prognostic Impact of HER2 and ER Status of Circulating Tumor Cells in Metastatic Breast Cancer Patients with a HER2-Negative Primary Tumor. Neoplasia. 18(11). 647–653. 40 indexed citations
19.
20.
Beije, Nick, Agnes Jager, & Stefan Sleijfer. (2014). Circulating tumor cell enumeration by the CellSearch system: The clinician’s guide to breast cancer treatment?. Cancer Treatment Reviews. 41(2). 144–150. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ninad Dewal Breakdown of academic impact, for papers by Marco Petronio Breakdown of academic impact, for papers by Samia Melaabi Breakdown of academic impact, for papers by Yuji Shimoda Breakdown of academic impact, for papers by Katja Fischereder Breakdown of academic impact, for papers by Maria Chimonidou Breakdown of academic impact, for papers by Imke Müller Breakdown of academic impact, for papers by Amber Anderson Breakdown of academic impact, for papers by Pauline Gilson Breakdown of academic impact, for papers by Brian Datnow
Rankless by CCL
2026